Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: a retrospective review of 22 patients.

ABSTRACT:

Background

Thymomas can benefit of cytoreductive surgery even if a complete resection is not feasible. The pleural cavity is the most common site of progression and the resection of pleural metastases can be performed in selected patients. We evaluated the results of stereotactic body radiation therapy for the treatment of pleural metastases in patients not eligible for surgery.

Methods

We retrospectively selected 22 patients treated with stereotactic body radiation therapy for pleural metastases between 2013 and 2019. According to RECIST criteria 1.1 modified for thymic epithelial tumors, time to local failure and progression free survival were calculated using Kaplan-Meier method.

Results

The median age was 40 years (range, 29-73 years). There were 1 A, 3 AB, 3 B1,

SUBMITTER: Pasquini G 

PROVIDER: S-EPMC8662497 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature